Related Experiment Video
Updated: Apr 9, 2026

09:21
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
12.8K
Acute Ischemic Stroke Treatment, Part 2: Treatment "Roles of Capillary Index Score, Revascularization and Time"
Firas Al-Ali1, John J Elias2, Danielle E Filipkowski2
1Department of Neuro Interventional Surgery, Akron General Medical Center , Akron, OH , USA.
Frontiers in Neurology
|June 18, 2015
Summary
Intra-arterial treatment for acute ischemic stroke (IAT-AIS) shows improved revascularization but not always good outcomes. A new capillary index score (CIS) may improve patient selection for IAT-AIS, leading to better results.
Area of Science:
- Neurology
- Interventional Radiology
- Stroke Medicine
Background:
- Clinical trials for intra-arterial treatment for acute ischemic stroke (IAT-AIS) have yielded mixed results regarding good clinical outcomes (GCOs).
- While intra-arterial treatment (IAT) improves revascularization rates, this has not consistently translated into better patient outcomes.
- Poor patient selection is suspected as a reason for suboptimal results in IAT-AIS.
Purpose of the Study:
- To introduce and evaluate the capillary index score (CIS) as a tool for improving patient selection in IAT-AIS.
- To determine if using CIS can enhance the likelihood of good clinical outcomes following revascularization.
- To propose a shift from time-based selection criteria to tissue viability assessment for IAT-AIS.
Main Methods:
- Literature review to identify factors limiting GCOs in IAT-AIS.
- Analysis of the capillary index score (CIS) as an angiography-based marker of tissue viability.
- Proposed use of CIS to select patients for IAT, focusing on residual viable tissue indicated by capillary blush.
Main Results:
- The CIS assesses capillary blush to differentiate viable from non-viable ischemic tissue.
- Absence of blush on angiography indicates non-viable tissue, suggesting futility of revascularization.
- Selecting patients with a favorable CIS is predicted to increase GCOs to 80-90%.
Conclusions:
- Current time-dependent selection for IAT-AIS may not be optimal due to inter-patient variability in ischemic progression.
- The CIS offers a more accurate method for patient selection by directly assessing tissue viability.
- Implementing CIS-based selection could significantly improve treatment efficacy and patient outcomes in IAT-AIS.
Keywords:
acute ischemic strokecapillary index scoreintra-arterial treatmentrevascularizationstroke outcomeMore Related Videos
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
485
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
485
Venous Thrombosis III: Interprofessional Care
466
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
466
Coronary Artery Disease V: Interprofessional Care
421
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
421

